Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Genetic variation in cytochrome P450 2J2 and soluble epoxide hydrolase and risk of ischemic stroke in a Chinese population.

Zhang L, Ding H, Yan J, Hui R, Wang W, Kissling GE, Zeldin DC, Wang DW.

Pharmacogenet Genomics. 2008 Jan;18(1):45-51. doi: 10.1097/FPC.0b013e3282f313e8.

2.

Association between polymorphisms of CYP2J2 and EPHX2 genes and risk of coronary artery disease.

Xu Y, Ding H, Peng J, Cui G, Liu L, Cianflone K, Wang DW.

Pharmacogenet Genomics. 2011 Aug;21(8):489-94. doi: 10.1097/FPC.0b013e3283485eb2.

PMID:
21642892
3.

Homozygosity for the EPHX2 K55R polymorphism increases the long-term risk of ischemic stroke in men: a study in Swedes.

Fava C, Montagnana M, Danese E, Almgren P, Hedblad B, Engström G, Berglund G, Minuz P, Melander O.

Pharmacogenet Genomics. 2010 Feb;20(2):94-103. doi: 10.1097/FPC.0b013e3283349ec9.

PMID:
20065888
4.

Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study.

Lee CR, North KE, Bray MS, Fornage M, Seubert JM, Newman JW, Hammock BD, Couper DJ, Heiss G, Zeldin DC.

Hum Mol Genet. 2006 May 15;15(10):1640-9. Epub 2006 Apr 4.

5.

Genetic variation in soluble epoxide hydrolase (EPHX2) is associated with an increased risk of ischemic stroke in white Europeans.

Gschwendtner A, Ripke S, Freilinger T, Lichtner P, Müller-Myhsok B, Wichmann HE, Meitinger T, Dichgans M.

Stroke. 2008 May;39(5):1593-6. doi: 10.1161/STROKEAHA.107.502179. Epub 2008 Mar 6.

6.

Common variation in cytochrome P450 epoxygenase genes and the risk of incident nonfatal myocardial infarction and ischemic stroke.

Marciante KD, Totah RA, Heckbert SR, Smith NL, Lemaitre RN, Lumley T, Rice KM, Hindorff LA, Bis JC, Hartman B, Psaty BM.

Pharmacogenet Genomics. 2008 Jun;18(6):535-43. doi: 10.1097/FPC.0b013e3282fd1287.

PMID:
18496133
7.

Genetically reduced soluble epoxide hydrolase activity and risk of stroke and other cardiovascular disease.

Lee J, Dahl M, Grande P, Tybjaerg-Hansen A, Nordestgaard BG.

Stroke. 2010 Jan;41(1):27-33. doi: 10.1161/STROKEAHA.109.567768. Epub 2009 Nov 25.

8.

CYP2C8 rs17110453 and EPHX2 rs751141 two-locus interaction increases susceptibility to ischemic stroke.

Yi X, Zhang B, Wang C, Liao D, Lin J, Chi L.

Gene. 2015 Jul 1;565(1):85-9. doi: 10.1016/j.gene.2015.03.068. Epub 2015 Mar 31.

PMID:
25839935
9.

Interaction among CYP2C8, EPHX2, and CYP4A11 Gene Variants Significantly Increases the Risk for Ischemic Stroke in Chinese Populations.

Yi X, Liao D, Fu X, Zhang B, Wang C.

J Atheroscler Thromb. 2015;22(11):1148-57. doi: 10.5551/jat.29025. Epub 2015 May 1.

10.

Genetic variation in the G-50T polymorphism of the cytochrome P450 epoxygenase CYP2J2 gene and the risk of younger onset type 2 diabetes among Chinese population: potential interaction with body mass index and family history.

Wang CP, Hung WC, Yu TH, Chiu CA, Lu LF, Chung FM, Hung CH, Shin SJ, Chen HJ, Lee YJ.

Exp Clin Endocrinol Diabetes. 2010 Jun;118(6):346-52. doi: 10.1055/s-0029-1243604. Epub 2010 Feb 5.

PMID:
20140850
11.

The soluble epoxide hydrolase gene harbors sequence variation associated with susceptibility to and protection from incident ischemic stroke.

Fornage M, Lee CR, Doris PA, Bray MS, Heiss G, Zeldin DC, Boerwinkle E.

Hum Mol Genet. 2005 Oct 1;14(19):2829-37. Epub 2005 Aug 22.

12.

Association of CYP2J2 gene polymorphisms with ischemic stroke and stroke subtypes in Chinese population.

Wang SY, Xing PF, Zhang CY, Deng BQ.

Medicine (Baltimore). 2017 Mar;96(10):e6266. doi: 10.1097/MD.0000000000006266.

13.

Genetic polymorphisms of ALOX5AP and CYP3A5 increase susceptibility to ischemic stroke and are associated with atherothrombotic events in stroke patients.

Yi X, Zhang B, Wang C, Liao D, Lin J, Chi L.

J Stroke Cerebrovasc Dis. 2015 Mar;24(3):521-9. doi: 10.1016/j.jstrokecerebrovasdis.2014.09.035. Epub 2014 Dec 19.

PMID:
25534367
14.

Altered soluble epoxide hydrolase gene expression and function and vascular disease risk in the stroke-prone spontaneously hypertensive rat.

Corenblum MJ, Wise VE, Georgi K, Hammock BD, Doris PA, Fornage M.

Hypertension. 2008 Feb;51(2):567-73. Epub 2007 Dec 17.

15.

Polymorphisms in the human soluble epoxide hydrolase gene EPHX2 linked to neuronal survival after ischemic injury.

Koerner IP, Jacks R, DeBarber AE, Koop D, Mao P, Grant DF, Alkayed NJ.

J Neurosci. 2007 Apr 25;27(17):4642-9.

16.

The CYP2J2 G-50T polymorphism and myocardial infarction in patients with cardiovascular risk profile.

Börgel J, Bulut D, Hanefeld C, Neubauer H, Mügge A, Epplen JT, Holland-Letz T, Spiecker M.

BMC Cardiovasc Disord. 2008 Dec 23;8:41. doi: 10.1186/1471-2261-8-41.

17.

The common functional polymorphism -50G>T of the CYP2J2 gene is not associated with ischemic coronary and cerebrovascular events in an urban-based sample of Swedes.

Fava C, Montagnana M, Almgren P, Hedblad B, Engström G, Berglund G, Minuz P, Melander O.

J Hypertens. 2010 Feb;28(2):294-9. doi: 10.1097/HJH.0b013e328333097e.

PMID:
19851119
18.

Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2.

Spiecker M, Darius H, Hankeln T, Soufi M, Sattler AM, Schaefer JR, Node K, Börgel J, Mügge A, Lindpaintner K, Huesing A, Maisch B, Zeldin DC, Liao JK.

Circulation. 2004 Oct 12;110(15):2132-6. Epub 2004 Oct 4.

19.

In vivo activity of epoxide hydrolase according to sequence variation affects the progression of human IgA nephropathy.

Lee JP, Yang SH, Kim DK, Lee H, Kim B, Cho JY, Yu KS, Paik JH, Kim M, Lim CS, Kim YS.

Am J Physiol Renal Physiol. 2011 Jun;300(6):F1283-90. doi: 10.1152/ajprenal.00733.2010. Epub 2011 Mar 23.

20.

Synergistic effect of cytochrome P450 epoxygenase CYP2J2*7 polymorphism with smoking on the onset of premature myocardial infarction.

Liu PY, Li YH, Chao TH, Wu HL, Lin LJ, Tsai LM, Chen JH.

Atherosclerosis. 2007 Nov;195(1):199-206. Epub 2006 Nov 28.

PMID:
17126841

Supplemental Content

Support Center